Pearl River Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,090
| Closed | -$1.41M | – | 94 |
|
|
2024
Q2 | $1.41M | Buy |
26,090
+20,132
| +338% | +$1.09M | 0.22% | 135 |
|
|
2024
Q1 | $406K | Sell |
5,958
-794
| -12% | -$54.1K | 0.06% | 332 |
|
|
2023
Q4 | $423K | Buy |
+6,752
| New | +$423K | 0.07% | 351 |
|
|
2021
Q4 | – | Sell |
-2,862
| Closed | -$320K | – | 445 |
|
|
2021
Q3 | $320K | Buy |
+2,862
| New | +$320K | 0.09% | 309 |
|
|
2019
Q2 | – | Sell |
-7,048
| Closed | -$252K | – | 316 |
|
|
2019
Q1 | $252K | Buy |
+7,048
| New | +$252K | 0.63% | 9 |
|